OKYO Cash from 2010 to 2024
| OKYO Stock | USD 1.06 0.01 0.93% |
Cash | First Reported 2008-03-31 | Previous Quarter 4 M | Current Value 4 M | Quarterly Volatility 5.4 M |
Check OKYO Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OKYO Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 K, Interest Expense of 1.1 M or Selling And Marketing Expenses of 1.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0254 or Days Sales Outstanding of 0.0. OKYO financial statements analysis is a perfect complement when working with OKYO Pharma Valuation or Volatility modules.
OKYO | Cash |
Latest OKYO Pharma's Cash Growth Pattern
Below is the plot of the Cash of OKYO Pharma Ltd over the last few years. Cash refers to the most liquid asset of OKYO Pharma, which is listed under current asset account on OKYO Pharma Ltd balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from OKYO Pharma customers. The amounts must be unrestricted with restricted cash listed in a different OKYO Pharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. OKYO Pharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OKYO Pharma's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
OKYO Cash Regression Statistics
| Arithmetic Mean | 6,320,347 | |
| Geometric Mean | 3,409,401 | |
| Coefficient Of Variation | 96.40 | |
| Mean Deviation | 4,880,080 | |
| Median | 4,045,381 | |
| Standard Deviation | 6,092,965 | |
| Sample Variance | 37.1T | |
| Range | 17.7M | |
| R-Value | (0.83) | |
| Mean Square Error | 12.3T | |
| R-Squared | 0.69 | |
| Significance | 0.0001 | |
| Slope | (1,133,267) | |
| Total Sum of Squares | 519.7T |
OKYO Cash History
Other Fundumenentals of OKYO Pharma
OKYO Pharma Cash component correlations
Click cells to compare fundamentals
About OKYO Pharma Financial Statements
OKYO Pharma investors utilize fundamental indicators, such as Cash, to predict how OKYO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 826.8 K | 785.5 K | |
| Cash And Short Term Investments | 826.8 K | 785.5 K | |
| Change In Cash | -3.2 M | -3.1 M | |
| Free Cash Flow | -9.5 M | -9 M | |
| Begin Period Cash Flow | 4 M | 3.8 M | |
| Other Cashflows From Financing Activities | 6.2 K | 5.9 K | |
| Other Non Cash Items | 3.5 M | 3.7 M | |
| Total Cash From Operating Activities | -9.5 M | -9 M | |
| Total Cash From Financing Activities | 6.2 M | 6.5 M | |
| End Period Cash Flow | 826.8 K | 785.5 K | |
| Total Cashflows From Investing Activities | -1.1 K | -1.2 K | |
| Other Cashflows From Investing Activities | -12.8 K | -13.5 K | |
| Free Cash Flow Yield | (0.22) | (0.21) | |
| Operating Cash Flow Per Share | (0.32) | (0.31) | |
| Free Cash Flow Per Share | (0.32) | (0.31) | |
| Cash Per Share | 0.03 | 0.03 | |
| EV To Operating Cash Flow | (4.46) | (4.68) | |
| EV To Free Cash Flow | (4.46) | (4.68) | |
| Price To Operating Cash Flows Ratio | (4.55) | (4.77) | |
| Price To Free Cash Flows Ratio | (4.55) | (4.77) | |
| Cash Ratio | 0.11 | 0.11 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.15 | 1.09 | |
| Cash Flow Coverage Ratios | (3.86) | (4.05) | |
| Price Cash Flow Ratio | (4.55) | (4.77) | |
| Cash Flow To Debt Ratio | (3.86) | (4.05) |
Pair Trading with OKYO Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OKYO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against OKYO Stock
| 0.38 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to OKYO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OKYO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OKYO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OKYO Pharma Ltd to buy it.
The correlation of OKYO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OKYO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of OKYO Pharma Correlation against competitors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (2.92) | Return On Equity (29.69) |
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.